Confluent (NASDAQ:CFLT - Get Free Report) announced its earnings results on Tuesday. The company reported ($0.23) EPS for the quarter, missing the consensus estimate of $0.05 by ($0.28), Zacks reports. Confluent had a negative net margin of 38.35% and a negative return on equity of 34.05%. Confluent updated its FY 2025 guidance to 0.350-0.350 EPS and its Q1 2025 guidance to 0.060-0.070 EPS.
Confluent Stock Down 4.3 %
CFLT traded down $1.36 during trading on Tuesday, hitting $30.10. The stock had a trading volume of 10,607,082 shares, compared to its average volume of 4,296,510. The company has a market capitalization of $9.87 billion, a PE ratio of -27.12 and a beta of 0.92. Confluent has a twelve month low of $17.79 and a twelve month high of $35.07. The company has a debt-to-equity ratio of 1.17, a quick ratio of 4.24 and a current ratio of 4.24. The stock has a 50 day simple moving average of $29.52 and a two-hundred day simple moving average of $25.25.
Wall Street Analyst Weigh In
CFLT has been the subject of several analyst reports. Mizuho increased their price objective on Confluent from $31.00 to $35.00 and gave the stock an "outperform" rating in a research note on Friday, December 13th. Citigroup increased their price objective on Confluent from $24.00 to $25.00 and gave the company a "neutral" rating in a report on Tuesday, October 29th. Needham & Company LLC reissued a "buy" rating and set a $31.00 price objective on shares of Confluent in a report on Friday, November 15th. Scotiabank raised their price target on Confluent from $25.00 to $27.00 and gave the stock a "sector perform" rating in a report on Thursday, October 31st. Finally, UBS Group raised their price target on Confluent from $23.00 to $26.00 and gave the stock a "neutral" rating in a report on Thursday, October 31st. One investment analyst has rated the stock with a sell rating, eight have given a hold rating, nineteen have issued a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, Confluent currently has an average rating of "Moderate Buy" and a consensus target price of $32.30.
View Our Latest Stock Report on Confluent
Insider Transactions at Confluent
In related news, Director Matthew Craig Miller sold 1,084,259 shares of the firm's stock in a transaction on Wednesday, November 13th. The shares were sold at an average price of $28.90, for a total transaction of $31,335,085.10. Following the completion of the transaction, the director now owns 12,559 shares of the company's stock, valued at $362,955.10. This trade represents a 98.85 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Edward Jay Kreps sold 232,500 shares of Confluent stock in a transaction on Wednesday, November 13th. The shares were sold at an average price of $29.29, for a total transaction of $6,809,925.00. Following the completion of the transaction, the chief executive officer now directly owns 452,488 shares of the company's stock, valued at $13,253,373.52. The trade was a 33.94 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 2,825,395 shares of company stock worth $85,343,808. Company insiders own 13.82% of the company's stock.
Confluent Company Profile
(
Get Free Report)
Confluent, Inc operates a data streaming platform in the United States and internationally. The company provides platforms that allow customers to connect their applications, systems, and data layers, such as Confluent Cloud, a managed cloud-native software-as-a-service; and Confluent Platform, an enterprise-grade self-managed software.
Read More
![Earnings History for Confluent (NASDAQ:CFLT)](https://www.marketbeat.com/scripts/EarningsChart.ashx?Prefix=NASDAQ&Symbol=CFLT)
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you make your next trade, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis.
Our team has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and none of the big name stocks were on the list.
They believe these five stocks are the five best companies for investors to buy now...
See The Five Stocks Here
Before you consider Confluent, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Confluent wasn't on the list.
While Confluent currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for February 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.